Skip to main content
. Author manuscript; available in PMC: 2019 Mar 27.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2008 May;17(5):1277–1281. doi: 10.1158/1055-9965.EPI-07-2621

Table 3.

Adjusted odds ratios for the use of antihistamines stratified by history of asthma or allergies among glioma cases and controls, Harris County Adult Glioma Study, 2001–2006

Antihistamine use Controls (n = 600) Cases (n = 325) Odds ratio (95% CI)
No asthma or allergy history
 No use 362 259 Reference
 <10 y  21  14 0.91 (0.45, 1.84)
 ≥10 y  15  8 0.70 (0.29, 1.69)
 Any use  36  22 0.82 (0.47, 1.44)
Any asthma or allergy history
 No use 146  23 Reference
 <10 y  32  8 1.73 (0.69, 4.29)
 ≥10 y  24  13 3.56 (1.56, 8.14)
 Any use  56  21 2.54 (1.28, 5.03)

NOTE: The odds ratios were derived from unconditional logistic regression models, adjusting for age, gender, and race.